Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the earnings per share (EPS) high or low?
The earnings per share (EPS) of -16.53 is 94% above its 5-year average of -277.16, near the high end of its 5-year range (-653.00–-11.93).
11.39% below its 12-month average of -14.84.
Reported quarterly EPS; no daily interpolation. Q2 FY2026 (2026-06-30): -11.25.
EPS growth vs the same fiscal quarter in the prior fiscal year, last 34 comparable quarters.
EARNINGS PER SHARE (EPS)
-16.53
EARNINGS PER SHARE (EPS) AVG TTM
-14.84
EARNINGS PER SHARE (EPS) AVG 3Y
-116.30
EARNINGS PER SHARE (EPS) AVG 5Y
-277.16
EARNINGS PER SHARE (EPS) AVG 10Y
-366.13
EARNINGS PER SHARE (EPS) AVG 15Y
N/A
EARNINGS PER SHARE (EPS) AVG 20Y
N/A
CURRENT VS TTM AVG
-11.39%
CURRENT VS 3Y AVG
+85.79%
CURRENT VS 5Y AVG
+94.04%
CURRENT VS 10Y AVG
+95.49%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
Adial Pharmaceuticals, Inc.
Market Cap
$11.42M
Earnings Per Share (EPS)
-16.53
TTM Avg
-14.84
3Y Avg
-116.30
5Y Avg
-277.16
Market Cap
$11.41M
Earnings Per Share (EPS)
-0.60
TTM Avg
-2.13
3Y Avg
-4.47
5Y Avg
-13.49
Market Cap
$11.01M
Earnings Per Share (EPS)
-0.47
TTM Avg
-0.74
3Y Avg
-0.71
5Y Avg
-0.50
Market Cap
$11.95M
Earnings Per Share (EPS)
N/A
TTM Avg
-0.21
3Y Avg
-0.25
5Y Avg
-0.25
Market Cap
$10.86M
Earnings Per Share (EPS)
-3.20
TTM Avg
-7.58
3Y Avg
-60.73
5Y Avg
-69.78
Market Cap
$10.74M
Earnings Per Share (EPS)
-4.43
TTM Avg
-27.97
3Y Avg
-98701.49
5Y Avg
-256134.32
Market Cap
$12.46M
Earnings Per Share (EPS)
-5.75
TTM Avg
-5.10
3Y Avg
-9.55
5Y Avg
-8.93
Market Cap
$10.27M
Earnings Per Share (EPS)
-0.73
TTM Avg
-0.46
3Y Avg
-0.46
5Y Avg
-0.46
Market Cap
$12.63M
Earnings Per Share (EPS)
-0.79
TTM Avg
-0.84
3Y Avg
-2.55
5Y Avg
-4.78
| NAME | MARKET CAP | EARNINGS PER SHARE (EPS) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Adial Pharmaceuticals, Inc. (ADIL) | $11.42M | -16.53 | -14.84 | -116.30 | -277.16 |
| Biofrontera Inc. (BFRI)vs › | $11.41M | -0.60 | -2.13 | -4.47 | -13.49 |
| Bullfrog AI Holdings, Inc. Common Stock (BFRG)vs › | $11.01M | -0.47 | -0.74 | -0.71 | -0.50 |
| CytoMed Therapeutics Limited (GDTC)vs › | $11.95M | N/A | -0.21 | -0.25 | -0.25 |
| BioVie Inc. (BIVI)vs › | $10.86M | -3.20 | -7.58 | -60.73 | -69.78 |
| Cerenome, Inc. (CNSY)vs › | $10.74M | -4.43 | -27.97 | -98701.49 | -256134.32 |
| Cytosorbents Corporation (CTSO)vs › | $12.46M | -5.75 | -5.10 | -9.55 | -8.93 |
| Caring Brands, Inc. (CABR)vs › | $10.27M | -0.73 | -0.46 | -0.46 | -0.46 |
| Dare Bioscience, Inc. (DARE)vs › | $12.63M | -0.79 | -0.84 | -2.55 | -4.78 |
| Ainos, Inc. (AIMD)vs › | $9.79M | -2.52 | -2.51 | -3.38 | -3.13 |
Trailing EPS (TTM)
$-16.53
Forward EPS (Est.)
$-2.60
P/E Ratio
N/A
Formula: EPS = Net Income / Weighted Average Shares Outstanding
Why EPS matters:
EPS (Earnings Per Share) represents the portion of a company's profit allocated to each outstanding share. Higher EPS indicates greater profitability on a per-share basis.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EARNINGS PER SHARE (EPS) |
|---|---|
| 2025-12-31 | -11.93 |
| 2024-12-31 | -17.75 |
| 2023-12-31 | -136.00 |
| 2022-12-31 | -299.50 |
| 2021-12-31 | -653.00 |
| 2020-12-31 | -544.75 |
| 2019-12-31 | -545.00 |
| 2018-12-31 | -1527.50 |
| 2017-12-31 | -130.00 |
| 2016-12-31 | -55.00 |
| 2015-12-31 | -107.00 |
